Conformal Medical, Inc., a medical device company focused on reducing stroke in patients with atrial fibrillation (AFib). The company is preparing for a U.S. pivotal trial of its novel CLAAS® Technology, a next-generation solution for sealing the left atrial appendage in patients with aFib.